|
Form Serial Number: |
DA20180508E00255
|
1.
Date of relevant event: |
03/05/2018 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
01312 |
4.
Name of listed corporation: |
Tongfang Kontafarma Holdings Limited |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
5,593,863,777 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Huang |
(Other names) |
Yu |
|
|
|
10.
Name of director (Chinese): |
黃俞 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1711 | Miscellaneous Other (you must briefly describe the relevant event in the Supplementary Information box) | |
2201 | Interest of corporation controlled by you | |
2201 | Interest of corporation controlled by you | |
243,863,777 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 3,165,974,000 | 59.18 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 3,165,974,000 | 56.60 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| Long position | 3,165,974,000 |
|
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
深圳市奧融信投資發展有限公司 | 29/F, Yinglong Commercial Building, No. 11 Shangbao East Road, Futian District, Shenzhen, PRC (PRC) | Huang Yu | 99.00 | N | Long position | 3,165,974,000 |
|
深圳市華融泰資產管理有限公司 | 29/F, Yinglong Commercial Building, No. 11 Shangbao East Road, Futian District, Shenzhen, PRC (PRC) | 深圳市奧融信投資發展有限公司 | 52.00 | N | Long position | 3,165,974,000 |
|
Waranty Assets Management (HK) Limited | Room D, 10/F., Tower A, Billion Centre, 1 Wang Kwong Road, Kowloon Bay, Kowloon, Hong Kong (Hong Kong) | 深圳市華融泰資產管理有限公司 | 100.00 | N | Long position | 3,165,974,000 |
|
China Health Management Investment Limited | Unit 8, 3/F, Qwomar Trading Complex, Blackburne Road, Port Purcell, Road Town, Tortola, British Virgin Islands, VG1110 (British Virgin Islands) | Waranty Assets Management (HK) Limited | 100.00 | Y | Long position | 3,165,974,000 |
|
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
243,863,777 new shares were alloted and issued by Tongfang Kontafarma Holdings Limited (the "Company") pursuant to the sale and purchase agreement dated 23 January 2018 as disclosed in the Company’s announcements respectively dated 23 January 2018 and 3 May 2018 and the circular dated 27 February 2018.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
08/05/2018 (dd/mm/yyyy)
|
|